320 related articles for article (PubMed ID: 36751744)
1. Role of alternatives to antibiotics in mitigating the antimicrobial resistance crisis.
Gupta R; Sharma S
Indian J Med Res; 2022 Sep; 156(3):464-477. PubMed ID: 36751744
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens.
Imran M; Ahmad MN; Dasgupta A; Rana P; Srinivas N; Chopra S
Future Med Chem; 2022 Aug; 14(15):1133-1148. PubMed ID: 35861021
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and Unconventional Strategies to Contrast Antimicrobial Resistance: A Literature Review.
Vitiello A; Sabbatucci M; Boccellino M; Ponzo A; Langella R; Zovi A
Discov Med; 2023 Oct; 35(178):750-756. PubMed ID: 37811613
[TBL] [Abstract][Full Text] [Related]
4. Novel Antibacterials: Alternatives to Traditional Antibiotics.
Betts JW; Hornsey M; La Ragione RM
Adv Microb Physiol; 2018; 73():123-169. PubMed ID: 30262108
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics at the crossroads - Do we have any therapeutic alternatives to control the emergence and spread of antimicrobial resistance?
Sannathimmappa MB; Nambiar V; Aravindakshan R
J Educ Health Promot; 2021; 10():438. PubMed ID: 35071644
[TBL] [Abstract][Full Text] [Related]
6. Towards promising antimicrobial alternatives: The future of bacteriophage research and development in Saudi Arabia.
Alsaadi A; Imam M; Alghamdi AA; Alghoribi MF
J Infect Public Health; 2022 Dec; 15(12):1355-1362. PubMed ID: 36332378
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?
Pérez de la Lastra JM; Anand U; González-Acosta S; López MR; Dey A; Bontempi E; Morales delaNuez A
Front Immunol; 2022; 13():921483. PubMed ID: 35720330
[TBL] [Abstract][Full Text] [Related]
8. Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.
Ghosh C; Sarkar P; Issa R; Haldar J
Trends Microbiol; 2019 Apr; 27(4):323-338. PubMed ID: 30683453
[TBL] [Abstract][Full Text] [Related]
9. Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.
Dhingra S; Rahman NAA; Peile E; Rahman M; Sartelli M; Hassali MA; Islam T; Islam S; Haque M
Front Public Health; 2020; 8():535668. PubMed ID: 33251170
[TBL] [Abstract][Full Text] [Related]
10. Impact of vaccines on antimicrobial resistance.
Buchy P; Ascioglu S; Buisson Y; Datta S; Nissen M; Tambyah PA; Vong S
Int J Infect Dis; 2020 Jan; 90():188-196. PubMed ID: 31622674
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance, mechanisms and its clinical significance.
Abushaheen MA; Muzaheed ; Fatani AJ; Alosaimi M; Mansy W; George M; Acharya S; Rathod S; Divakar DD; Jhugroo C; Vellappally S; Khan AA; Shaik J; Jhugroo P
Dis Mon; 2020 Jun; 66(6):100971. PubMed ID: 32201008
[TBL] [Abstract][Full Text] [Related]
12. A Quest to the Therapeutic Arsenal: Novel Strategies to Combat Multidrug- resistant Bacteria.
Ashwath P; Sannejal AD
Curr Gene Ther; 2022; 22(2):79-88. PubMed ID: 33874870
[TBL] [Abstract][Full Text] [Related]
13. Global geographic trends in antimicrobial resistance: the role of international travel.
Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
[TBL] [Abstract][Full Text] [Related]
14. Will the mRNA vaccine platform be the panacea for the development of vaccines against antimicrobial resistant (AMR) pathogens?
Chen W
Expert Rev Vaccines; 2022 Feb; 21(2):155-157. PubMed ID: 34818960
[No Abstract] [Full Text] [Related]
15. Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics?
Brunel AS; Guery B
Swiss Med Wkly; 2017; 147():w14553. PubMed ID: 29185252
[TBL] [Abstract][Full Text] [Related]
16. The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance.
Lopes BS; Hanafiah A; Nachimuthu R; Muthupandian S; Md Nesran ZN; Patil S
Molecules; 2022 May; 27(9):. PubMed ID: 35566343
[TBL] [Abstract][Full Text] [Related]
17. Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics.
Murugaiyan J; Kumar PA; Rao GS; Iskandar K; Hawser S; Hays JP; Mohsen Y; Adukkadukkam S; Awuah WA; Jose RAM; Sylvia N; Nansubuga EP; Tilocca B; Roncada P; Roson-Calero N; Moreno-Morales J; Amin R; Kumar BK; Kumar A; Toufik AR; Zaw TN; Akinwotu OO; Satyaseela MP; van Dongen MBM
Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203804
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of emerging resistance associated with non-antibiotic antimicrobial agents: a state-of-the-art review.
Baig MIR; Kadu P; Bawane P; Nakhate KT; Yele S; Ojha S; Goyal SN
J Antibiot (Tokyo); 2023 Nov; 76(11):629-641. PubMed ID: 37605076
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.
Bassetti M; Poulakou G; Ruppe E; Bouza E; Van Hal SJ; Brink A
Intensive Care Med; 2017 Oct; 43(10):1464-1475. PubMed ID: 28733718
[TBL] [Abstract][Full Text] [Related]
20. Phage therapeutics: from promises to practices and prospectives.
Bhargava K; Nath G; Bhargava A; Aseri GK; Jain N
Appl Microbiol Biotechnol; 2021 Dec; 105(24):9047-9067. PubMed ID: 34821965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
